• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
Framework to Classify Reverse Cardiac Remodeling With Mechanical Circulatory Support: The Utah-Inova Stages.带有机械循环支持的逆向心脏重构的分类框架:犹他州-因诺瓦分期。
Circ Heart Fail. 2021 May;14(5):e007991. doi: 10.1161/CIRCHEARTFAILURE.120.007991. Epub 2021 May 5.
2
LVAD decommissioning for myocardial recovery: Long-term ventricular remodeling and adverse events.左心室辅助装置(LVAD)的拆除与心肌恢复:长期心室重构和不良事件。
J Heart Lung Transplant. 2021 Dec;40(12):1560-1570. doi: 10.1016/j.healun.2021.08.001. Epub 2021 Aug 11.
3
Assessment of myocardial viability and left ventricular function in patients supported by a left ventricular assist device.评估左心室辅助装置支持患者的心肌活力和左心室功能。
J Heart Lung Transplant. 2014 Apr;33(4):372-81. doi: 10.1016/j.healun.2014.01.866. Epub 2014 Jan 27.
4
Myocardial atrophy and chronic mechanical unloading of the failing human heart: implications for cardiac assist device-induced myocardial recovery.心肌萎缩和衰竭人类心脏的慢性机械卸载:对心脏辅助装置诱导心肌恢复的影响。
J Am Coll Cardiol. 2014 Oct 14;64(15):1602-12. doi: 10.1016/j.jacc.2014.05.073.
5
Incomplete recovery of myocyte contractile function despite improvement of myocardial architecture with left ventricular assist device support.尽管左心室辅助装置支持改善了心肌结构,但心肌收缩功能仍未完全恢复。
Circ Heart Fail. 2011 Jul;4(4):425-32. doi: 10.1161/CIRCHEARTFAILURE.111.961326. Epub 2011 May 3.
6
Left Ventricular Hemodynamics and Relationship With Myocardial Recovery and Optimization in Patients Supported on CF-LVAD Therapy.接受连续流左心室辅助装置(CF-LVAD)治疗患者的左心室血流动力学及其与心肌恢复和优化的关系
J Card Fail. 2022 May;28(5):799-806. doi: 10.1016/j.cardfail.2021.12.008. Epub 2021 Dec 17.
7
Structural and functional cardiac profile after prolonged duration of mechanical unloading: potential implications for myocardial recovery.机械卸载时间延长后的心脏结构和功能特征:对心肌恢复的潜在影响。
Am J Physiol Heart Circ Physiol. 2018 Nov 1;315(5):H1463-H1476. doi: 10.1152/ajpheart.00187.2018. Epub 2018 Aug 24.
8
Magnitude and time course of changes induced by continuous-flow left ventricular assist device unloading in chronic heart failure: insights into cardiac recovery.连续血流左心室辅助装置卸载在慢性心力衰竭中诱导的变化幅度和时程:对心脏恢复的深入了解。
J Am Coll Cardiol. 2013 May 14;61(19):1985-94. doi: 10.1016/j.jacc.2013.01.072. Epub 2013 Mar 14.
9
Prospective Multicenter Study of Myocardial Recovery Using Left Ventricular Assist Devices (RESTAGE-HF [Remission from Stage D Heart Failure]): Medium-Term and Primary End Point Results.采用左心室辅助装置的心肌恢复前瞻性多中心研究(RESTAGE-HF[心力衰竭 D 期缓解]):中期和主要终点结果。
Circulation. 2020 Nov 24;142(21):2016-2028. doi: 10.1161/CIRCULATIONAHA.120.046415. Epub 2020 Oct 26.
10
Impact of Diabetes and Glycemia on Cardiac Improvement and Adverse Events Following Mechanical Circulatory Support.糖尿病和血糖对机械循环支持后心脏改善和不良事件的影响。
J Am Heart Assoc. 2024 Jul 16;13(14):e032936. doi: 10.1161/JAHA.123.032936. Epub 2024 Jul 11.

引用本文的文献

1
From support to recovery: the evolving role of LVAD in reversing heart failure.从支持到康复:左心室辅助装置在逆转心力衰竭中不断演变的作用
J Cardiothorac Surg. 2025 Aug 19;20(1):340. doi: 10.1186/s13019-025-03560-1.
2
Left Atrial Reverse Remodeling in Patients Supported With Durable Left Ventricular Assist Devices and Clinical Implications.接受长期左心室辅助装置支持的患者的左心房逆向重构及其临床意义
Circ Heart Fail. 2025 Jul;18(7):e012807. doi: 10.1161/CIRCHEARTFAILURE.125.012807. Epub 2025 May 13.
3
Myocardial functional recovery following durable ventricular assist device in children.儿童使用持久性心室辅助装置后的心肌功能恢复
JHLT Open. 2024 Nov 17;7:100181. doi: 10.1016/j.jhlto.2024.100181. eCollection 2025 Feb.
4
A Latent Cardiomyocyte Regeneration Potential in Human Heart Disease.人类心脏病中潜在的心肌细胞再生潜力。
Circulation. 2025 Jan 21;151(3):245-256. doi: 10.1161/CIRCULATIONAHA.123.067156. Epub 2024 Nov 21.
5
Myocardial Recovery in the Systemic Context: A Philosophic Shift for the Heart Failure Subspecialty to Optimize Patient Care.从整体角度看心肌恢复:心力衰竭亚专科优化患者治疗的哲学转变
Methodist Debakey Cardiovasc J. 2024 Aug 20;20(4):98-108. doi: 10.14797/mdcvj.1416. eCollection 2024.
6
Impact of Diabetes and Glycemia on Cardiac Improvement and Adverse Events Following Mechanical Circulatory Support.糖尿病和血糖对机械循环支持后心脏改善和不良事件的影响。
J Am Heart Assoc. 2024 Jul 16;13(14):e032936. doi: 10.1161/JAHA.123.032936. Epub 2024 Jul 11.
7
Cardiac Reverse Remodeling Mediated by HeartMate 3 Left Ventricular Assist Device: Comparison to Older Generation Devices.HeartMate 3左心室辅助装置介导的心脏逆向重构:与前代装置的比较。
ASAIO J. 2024 Dec 1;70(12):1060-1066. doi: 10.1097/MAT.0000000000002245. Epub 2024 May 28.
8
Baseline QRS duration associates with cardiac recovery in patients with continuous-flow left ventricular assist device implantation.基线QRS时限与连续流左心室辅助装置植入患者的心脏恢复相关。
Am Heart J Plus. 2022 Sep 17;22:100211. doi: 10.1016/j.ahjo.2022.100211. eCollection 2022 Oct.
9
Sex-Linked Differences in Cardiac Atrophy After Mechanical Unloading Induced by Heterotopic Heart Transplantation.异位心脏移植诱导的机械卸载后心脏萎缩的性连锁差异
Physiol Res. 2024 Mar 11;73(1):9-25. doi: 10.33549/physiolres.935217.
10
Advanced Heart Failure: Therapeutic Options and Challenges in the Evolving Field of Left Ventricular Assist Devices.晚期心力衰竭:左心室辅助装置不断发展领域中的治疗选择与挑战
J Cardiovasc Dev Dis. 2024 Feb 16;11(2):61. doi: 10.3390/jcdd11020061.

本文引用的文献

1
Prospective Multicenter Study of Myocardial Recovery Using Left Ventricular Assist Devices (RESTAGE-HF [Remission from Stage D Heart Failure]): Medium-Term and Primary End Point Results.采用左心室辅助装置的心肌恢复前瞻性多中心研究(RESTAGE-HF[心力衰竭 D 期缓解]):中期和主要终点结果。
Circulation. 2020 Nov 24;142(21):2016-2028. doi: 10.1161/CIRCULATIONAHA.120.046415. Epub 2020 Oct 26.
2
Neurohormonal Blockade and Clinical Outcomes in Patients With Heart Failure Supported by Left Ventricular Assist Devices.左心室辅助装置支持的心力衰竭患者的神经激素阻断和临床结局。
JAMA Cardiol. 2020 Feb 1;5(2):175-182. doi: 10.1001/jamacardio.2019.4965.
3
Imaging, Biomarker, and Clinical Predictors of Cardiac Remodeling in Heart Failure With Reduced Ejection Fraction.心力衰竭伴射血分数降低患者心脏重构的影像学、生物标志物和临床预测因子。
JACC Heart Fail. 2019 Sep;7(9):782-794. doi: 10.1016/j.jchf.2019.06.004. Epub 2019 Aug 7.
4
Clinical and histopathological effects of heart failure drug therapy in advanced heart failure patients on chronic mechanical circulatory support.心力衰竭药物治疗对慢性机械循环辅助支持的晚期心力衰竭患者的临床和组织病理学影响。
Eur J Heart Fail. 2018 Jan;20(1):164-174. doi: 10.1002/ejhf.1018. Epub 2017 Nov 1.
5
Reverse remodelling and myocardial recovery in heart failure.心力衰竭中的逆重构和心肌恢复。
Nat Rev Cardiol. 2018 Feb;15(2):83-96. doi: 10.1038/nrcardio.2017.139. Epub 2017 Sep 21.
6
Advancing the Science of Myocardial Recovery With Mechanical Circulatory Support: A Working Group of the National, Heart, Lung, and Blood Institute.借助机械循环支持推进心肌恢复科学:国家心肺血液研究所工作组
JACC Basic Transl Sci. 2017 Jun;2(3):335-340. doi: 10.1016/j.jacbts.2016.12.003.
7
Cell-Specific Pathways Supporting Persistent Fibrosis in Heart Failure.细胞特异性通路支持心力衰竭中的持续性纤维化。
J Am Coll Cardiol. 2017 Jul 18;70(3):344-354. doi: 10.1016/j.jacc.2017.05.040.
8
Unrecognized Left Heart Failure in LVAD Recipients: The Role of Routine Invasive Hemodynamic Testing.左心衰竭在左心室辅助装置(LVAD)受者中未被识别:常规有创血流动力学检测的作用。
ASAIO J. 2018 Mar/Apr;64(2):183-190. doi: 10.1097/MAT.0000000000000617.
9
Advancing the Science of Myocardial Recovery With Mechanical Circulatory Support: A Working Group of the National, Heart, Lung and Blood Institute.利用机械循环支持推进心肌恢复的科学:国家心肺血液研究所的一个工作组。
J Card Fail. 2017 May;23(5):416-421. doi: 10.1016/j.cardfail.2017.04.005. Epub 2017 Apr 19.
10
Impact of Ischemic Heart Failure Etiology on Cardiac Recovery During Mechanical Unloading.缺血性心力衰竭病因对机械卸载期间心脏恢复的影响。
J Am Coll Cardiol. 2016 Oct 18;68(16):1741-1752. doi: 10.1016/j.jacc.2016.07.756.

带有机械循环支持的逆向心脏重构的分类框架:犹他州-因诺瓦分期。

Framework to Classify Reverse Cardiac Remodeling With Mechanical Circulatory Support: The Utah-Inova Stages.

机构信息

Heart Failure, Mechanical Circulatory Support and Transplant (P.S., M.P., M.A.S., F.L., N.I., W.Z., C.W.M.), Inova Heart and Vascular Institute, Falls Church, Virginia.

Utah Transplant Affiliated Hospitals (U.T.A.H.) Cardiac Transplant Program, University of Utah Health and School of Medicine, Intermountain Medical Center and Salt Lake Veterans Affairs Medical Center (I.T., R.A., O.W.-P., M.Y., J.S., J.C.F., C.P.K., L.B.C., S.S.D., C.H.S., A.K., S.G.D.).

出版信息

Circ Heart Fail. 2021 May;14(5):e007991. doi: 10.1161/CIRCHEARTFAILURE.120.007991. Epub 2021 May 5.

DOI:10.1161/CIRCHEARTFAILURE.120.007991
PMID:33947201
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8137588/
Abstract

BACKGROUND

Variable definitions and an incomplete understanding of the gradient of reverse cardiac remodeling following continuous flow left ventricular assist device (LVAD) implantation has limited the field of myocardial plasticity. We evaluated the continuum of LV remodeling by serial echocardiographic imaging to define 3 stages of reverse cardiac remodeling following LVAD.

METHODS

The study enrolled consecutive LVAD patients across 4 study sites. A blinded echocardiographer evaluated the degree of structural (LV internal dimension at end-diastole [LVIDd]) and functional (LV ejection fraction [LVEF]) change after LVAD. Patients experiencing an improvement in LVEF ≥40% and LVIDd ≤6.0 cm were termed responders, absolute change in LVEF of ≥5% and LVEF <40% were termed partial responders, and the remaining patients with no significant improvement in LVEF were termed nonresponders.

RESULTS

Among 358 LVAD patients, 34 (10%) were responders, 112 (31%) partial responders, and the remaining 212 (59%) were nonresponders. The use of guideline-directed medical therapy for heart failure was higher in partial responders and responders. Structural changes (LVIDd) followed a different pattern with significant improvements even in patients who had minimal LVEF improvement. With mechanical unloading, the median reduction in LVIDd was -0.6 cm (interquartile range [IQR], -1.1 to -0.1 cm; nonresponders), -1.1 cm (IQR, -1.8 to -0.4 cm; partial responders), and -1.9 cm (IQR, -2.9 to -1.1 cm; responders). Similarly, the median change in LVEF was -2% (IQR, -6% to 1%), 9% (IQR, 6%-14%), and 27% (IQR, 23%-33%), respectively.

CONCLUSIONS

Reverse cardiac remodeling associated with durable LVAD support is not an all-or-none phenomenon and manifests in a continuous spectrum. Defining 3 stages across this continuum can inform clinical management, facilitate the field of myocardial plasticity, and improve the design of future investigations.

摘要

背景

由于变量定义不明确以及对连续流动左心室辅助装置(LVAD)植入后逆向心脏重构梯度的理解不完整,限制了心肌可塑性领域的发展。我们通过连续超声心动图成像评估 LV 重构的连续体,以定义 LVAD 后逆向心脏重构的 3 个阶段。

方法

该研究在 4 个研究地点连续招募了 LVAD 患者。一位经过盲法培训的超声心动图医师评估了 LVAD 后结构(LV 舒张末期内径 [LVIDd])和功能(LV 射血分数 [LVEF])变化的程度。LVAD 后 LVEF 改善≥40%且 LVIDd≤6.0 cm 的患者被称为反应者,LVEF 绝对变化≥5%且 LVEF<40%的患者被称为部分反应者,而其余 LVEF 无明显改善的患者被称为无反应者。

结果

在 358 例 LVAD 患者中,34 例(10%)为反应者,112 例(31%)为部分反应者,其余 212 例(59%)为无反应者。部分反应者和反应者使用指南指导的心力衰竭药物治疗的比例更高。结构变化(LVIDd)呈现出不同的模式,即使在 LVEF 改善最小的患者中也有明显改善。随着机械卸载,LVIDd 的中位数减少量分别为-0.6 cm(四分位距 [IQR],-1.1 至-0.1 cm;无反应者)、-1.1 cm(IQR,-1.8 至-0.4 cm;部分反应者)和-1.9 cm(IQR,-2.9 至-1.1 cm;反应者)。同样,LVEF 的中位数变化分别为-2%(IQR,-6%至 1%)、9%(IQR,6%-14%)和 27%(IQR,23%-33%)。

结论

与持久的 LVAD 支持相关的逆向心脏重构不是一种全有或全无的现象,而是表现为一个连续的谱。在这个连续体上定义 3 个阶段可以为临床管理提供信息,促进心肌可塑性领域的发展,并改进未来研究的设计。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/52ff/8137588/5ac28909cc6d/nihms-1677992-f0005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/52ff/8137588/d9f51e4d857e/nihms-1677992-f0001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/52ff/8137588/30eea6209027/nihms-1677992-f0002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/52ff/8137588/e7b97423f6c7/nihms-1677992-f0003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/52ff/8137588/7cf987f50548/nihms-1677992-f0004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/52ff/8137588/5ac28909cc6d/nihms-1677992-f0005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/52ff/8137588/d9f51e4d857e/nihms-1677992-f0001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/52ff/8137588/30eea6209027/nihms-1677992-f0002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/52ff/8137588/e7b97423f6c7/nihms-1677992-f0003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/52ff/8137588/7cf987f50548/nihms-1677992-f0004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/52ff/8137588/5ac28909cc6d/nihms-1677992-f0005.jpg